Company Overview
Snapshot
Founded in August 2008 by Shimon Eckhouse and Ronen Eckhouse, Rapid Medical operates with 51–200 employees. The company has raised $82.31M across 7 funding rounds from 14 investors.
Business overview
Rapid Medical develops neurovascular medical devices focused on safety and efficacy for patients and physicians. The company's product portfolio includes distal access catheters, adjustable remodeling mesh for microcatheters, and steerable guidewires. Its offerings, such as the Tigertriever 13, Comaneci, and Drivewire (Columbus outside the U.S.), are designed to treat vascular diseases with less invasive interventional approaches, serving the health tech and life sciences sector.
Strategic signal
Rapid Medical has expanded its global market reach and product validation. In December 2023, the company announced Japanese approval and an exclusive partnership with Kaneka for its TIGERTRIEVER device, following approval in China for the same adjustable thrombectomy device in August 2023. This strategic expansion into key Asian markets signals strong international validation and commercial growth potential for its neurovascular technologies.
Log in to access full profile ›Company Intelligence Q&A
- What is Rapid Medical's primary focus?
- Rapid Medical develops safe and effective neurovascular medical devices designed to benefit patients while meeting the needs of physicians. Its products include distal access catheters and adjustable remodeling mesh for microcatheters.
- When was Rapid Medical founded and by whom?
- Rapid Medical was founded in August 2008 by Shimon Eckhouse and Ronen Eckhouse.
- What significant regulatory milestone did Rapid Medical achieve in July 2022?
- In July 2022, Rapid Medical gained FDA clearance for its adjustable thrombectomy device, marking a significant regulatory achievement for its smallest and only adjustable device of its kind.
- What was a key strategic development for Rapid Medical in December 2023?
- In December 2023, Rapid Medical announced Japanese approval and an exclusive partnership with Kaneka for its TIGERTRIEVER, the world's only adjustable thrombectomy device, expanding its market reach.